gemcitabine has been researched along with mocetinostat in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Brady, H; Heise, C; Kelter, G; Maier, A; Richard, N; Sung, V | 1 |
| Batte, K; Bid, HK; Braggio, D; Casadei, L; Choy, E; Iwenofu, OH; Koller, D; Lev, D; Lopez, G; Pollock, R; Strohecker, A; Yu, P; Zewdu, A | 1 |
| Alcindor, T; Chan, E; Chao, R; Chiorean, EG; Gabrail, NY; Hurwitz, H; O'Dwyer, PJ; Potvin, D | 1 |
| Li, N; Qi, Y; Yu, D; Zhan, J; Zhang, G; Zhao, Q | 1 |
1 trial(s) available for gemcitabine and mocetinostat
| Article | Year |
|---|---|
Phase I/II study of mocetinostat in combination with gemcitabine for patients with advanced pancreatic cancer and other advanced solid tumors.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cohort Studies; Deoxycytidine; Endpoint Determination; Female; Gemcitabine; Histone Deacetylase Inhibitors; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Pancreatic Neoplasms; Pyrimidines; Treatment Outcome | 2018 |
5 other study(ies) available for gemcitabine and mocetinostat
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Histone deacetylase inhibitor MGCD0103 synergizes with gemcitabine in human pancreatic cells.
Topics: Apoptosis; Benzamides; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Drug Synergism; Gemcitabine; Gene Expression; Histone Deacetylase Inhibitors; Humans; Immunoblotting; Pancreas; Pancreatic Neoplasms; Pyrimidines | 2011 |
Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlates.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Cell Division; Cell Line, Tumor; Deoxycytidine; Drug Synergism; Gemcitabine; Humans; Leiomyosarcoma; Pyrimidines | 2017 |
Synergistic ferroptosis-gemcitabine chemotherapy of the gemcitabine loaded carbonaceous nanozymes to enhance the treatment and magnetic resonance imaging monitoring of pancreatic cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Line, Tumor; Deoxycytidine; Ferroptosis; Gemcitabine; Glutathione Peroxidase; Humans; Magnetic Resonance Imaging; Pancreatic Neoplasms; Peroxidase; Reactive Oxygen Species | 2022 |